34
Views
0
CrossRef citations to date
0
Altmetric
NEUROLOGY

Assessment of disease pattern and drug utilization among neurology intensive care unit patients in a developing country: an observational analysis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Received 07 Jan 2024, Accepted 20 May 2024, Published online: 30 May 2024

References

  • Carroll WM. The global burden of neurological disorders. Lancet Neurol. 2019;18(5):418–419. doi: 10.1016/S1474-4422(19)30029-8
  • Gourie-Devi M. Epidemiology of neurological disorders in India: review of background, prevalence and incidence of epilepsy, stroke, Parkinson’s disease and tremors. Neurol India. 2014;62(6):588–598. doi: 10.4103/0028-3886.149365
  • Mehndiratta MM, Aggarwal V. Neurological disorders in India: past, present, and next steps. Lancet Glob Health. 2021;9(8):e1043–1044. doi: 10.1016/S2214-109X(21)00214-X
  • Feigin VL, Nichols E, Alam T, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459–480. doi: 10.1016/S1474-4422(18)30499-X
  • Grant IS, Andrews PJ. ABC of intensive care: neurological support. BMJ. 1999;319(7202):110–113. doi: 10.1136/bmj.319.7202.110
  • Zauner A, Daugherty WP, Bullock MR, et al. Brain oxygenation and energy metabolism: part I—biological function and pathophysiology. Neurosurg. 2002;51(2):289–302. doi: 10.1097/00006123-200208000-00003
  • Borel C, Hanley D. Neurologic intensive care unit monitoring. Crit Care Clin. 1985;1(2):223–239. doi: 10.1016/S0749-0704(18)30656-0
  • Howard RS, Kullmann DM, Hirsch NP. Admission to neurological intensive care: who, when, and why? J Neurol Neurosurg Psychiatry. 2003;74(90003):2iii–9. doi: 10.1136/jnnp.74.suppl_3.iii2
  • World Health Organization. Introduction to drug utilization research. Geneva, Switzerland: World Health Organization; 2003 https://iris.who.int/bitstream/handle/10665/42627/924156234X.pdf?sequence=1.
  • Guidelines for ATC classification and DDD assignment 2023. Available from: https://www.whocc.no/atc_ddd_index_and_guidelines/guidelines/
  • Natsch S, Hekster YA, de Jong R, et al. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis. 1998;17(1):20–24. doi: 10.1007/BF01584358
  • Ronning M, Blix HS, Harbø BT, et al. Different versions of the anatomical therapeutic chemical classification system and the defined daily dose – are drug utilisation data comparable? Eur J Clin Pharmacol. 2000;56(9–10):723–727. doi: 10.1007/s002280000200
  • Thomas A, Adake U, Sharma A, et al. Drug utilization pattern in adult medical intensive care unit of a tertiary care hospital. Chrismed J Health Res. 2019;6(1):35. doi: 10.4103/cjhr.cjhr_45_18
  • Shah R, Desai S, Gajjar B. Drug utilization pattern among geriatric patients assessed with the anatomical therapeutic chemical classification/defined daily dose system in a rural tertiary care teaching hospital. Int J Nutr Pharmacol Neurol Dis. 2012;2(3):258. doi: 10.4103/2231-0738.99480
  • Newale S, Bachani DS. Demographic characteristics of epilepsy patients and antiepileptic drug utilization in adult patients: results of a cross-sectional survey. Results of a cross-sectional survey. Neurol India. 2016;64(6):1180–1186. doi: 10.4103/0028-3886.193806
  • Mittal N, Mittal R, Singh I, et al. Drug utilisation study in a tertiary care center: recommendations for improving hospital drug dispensing policies. Indian J Pharm Sci. 2014;76(4):308–314.
  • Sahoo A, Gupta D, Dhaneria S, et al. Retrospective analysis of drug prescription statistics in a tertiary care center in India: recommendations for promoting prudent utilization of drugs. J Res Pharm Pract. 2020;9(3):146. doi: 10.4103/jrpp.JRPP_20_29
  • John LJ, Devi P, John J, et al. Utilization patterns of central nervous system drugs: a cross-sectional study among the critically ill patients. J Neurosci Rural Pract. 2011;2(2):119–123. doi: 10.4103/0976-3147.83574
  • Bose D, Sushma M, Agadi JB. Age- and gender-related differences in drug utilization patterns among patients in neurology ward of a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2017;7:754–761. doi: 10.5455/njppp.2017.7.0308024032017
  • Sood P, Bindra S. Modified kuppuswamy socioeconomic scale: 2022 update of India. Int J Community Med Public Health. 2022;9(10):3841–3844. doi: 10.18203/2394-6040.ijcmph20222581
  • Sternbach GL. The Glasgow coma scale. J Emerg Med. 2000;19(1):67–71. doi: 10.1016/S0736-4679(00)00182-7
  • World Health Organization. International classification of diseases for mortality and morbidity statistics. 11th Revision ed. Geneva: World Health Organization; 2021.
  • World Health Organization. How to investigate drug use in health facilities. Geneva, Switzerland; 1993. https://iris.who.int/bitstream/handle/10665/60519/WHO_DAP_93.1.pdf?sequence=1
  • National list of essential medicines (NLEM). Ministry of Health and Family Welfare; 2022. Available from: https://main.mohfw.gov.in/newshighlights-104
  • National programme for prevention and control of non communicable diseases guidelines for prevention and management of stroke. 2022.
  • Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack; a guideline from the American heart association/American stroke association. Stroke. 2021;52(7):e364–467. doi: 10.1161/STR.0000000000000375
  • Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American heart association/American stroke association. Stroke. 2022;53(7):e282–361. doi: 10.1161/STR.0000000000000407
  • Powers WJ, Rabinstein AA, Ackerson T, et al. American heart association stroke council. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American Stroke Association. Stroke. 2018;49(3):e46–e110. doi: 10.1161/STR.0000000000000158
  • Ovbiagele B, Nguyen-Huynh MN. Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics. 2011;8(3):319–329. doi: 10.1007/s13311-011-0053-1
  • Ghose M, Das M, Das R, et al. Homocysteine, vitamins B6, B12, and folate and the risk of ischemic and hemorrhagic stroke: a case-control study from Northeast India. Ann Neurosci. 2023;30(1):33–39. doi: 10.1177/09727531221124425
  • Gajurel BP, Parajuli P, Nepali R, et al. Spectrum of neurological disorders admitted in Tribhuvan University teaching hospital Maharajgunj. J Inst Med Nepal. 2012;34(3):50–53. doi: 10.3126/jiom.v34i3.8918
  • Awan S, Shafqat S, Kamal AK, et al. Pattern of neurological diseases in adult outpatient neurology clinics in tertiary care hospital. BMC Res Notes. 2017;10(1):10. doi: 10.1186/s13104-017-2873-5
  • Kaur S, Rajagopalan S, Kaur N, et al. Drug utilization study in medical emergency unit of a tertiary care hospital in North India. Emerg Med Int. 2014;2014:1–5. doi: 10.1155/2014/973578
  • Chowdhury RN, Hasan ATMH, Rahman YU, et al. Pattern of neurological disease seen among patients admitted in tertiary care hospital. BMC Res Notes. 2014;7(1). doi: 10.1186/1756-0500-7-202
  • Banerjee TK, Das SK. Fifty years of stroke researches in India. Ann Indian Acad Neurol. 2016;19(1):1–8. doi: 10.4103/0972-2327.168631
  • Esper AM, Martin GS. The impact of comorbid conditions on critical illness. Crit Care Med. 2011;39(12):2728–2735. doi: 10.1097/CCM.0b013e318236f27e
  • Patanaik SK, Pattanayak C, Prasad A, et al. Drug utilization pattern in an intensive care unit setting in Eastern India. Int J Basic Clin Pharmacol. 2015;4:1136–1141. doi: 10.18203/2319-2003.ijbcp20151347
  • Sarwar MR, Atif M, Scahill S, et al. Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan. J Pharm Policy Pract. 2017;10(1):1–16. doi: 10.1186/s40545-017-0112-z
  • Joshi SS, Shetty YC, Karande S. Generic drugs - the Indian scenario. J Postgrad Med. 2019;65(2):67–69. doi: 10.4103/jpgm.JPGM_420_18
  • Das Post I, Student G, In Education MA. Educational system and economic development of North-East India [Internet]. 2018. Available from: www.ijcrt.org
  • Shankarishan P, Borah PK, Mohapatra PK, et al. Population attributable risk estimates for risk factors associated with hypertension in an Indian population. Eur J Prev Cardiol. 2013;20(6):963–971. doi: 10.1177/2047487312462146
  • Arcidiacono P, Ellickson PB, Landry P, et al. Pharmaceutical followers. Int J Ind Organ. 2013;31(5):538–553. doi: 10.1016/j.ijindorg.2013.10.005
  • Nobili A, Franchi C, Pasina L, et al. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM‐elderly project. Pharmacoepidemiol Drug Saf. 2011;20:488–496. doi: 10.1002/pds.2108
  • Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Arterial Hypertension. 2013;31(7):1281–1357. doi: 10.1097/01.hjh.0000431740.32696.cc
  • Whiteford HA, Ferrari AJ, Degenhardt L, et al. The global burden of mental, neurological and substance use disorders: an analysis from the global burden of disease study 2010. PLOS ONE. 2015;10(2):e0116820. doi: 10.1371/journal.pone.0116820
  • Taskeen M, Rashid Ali S, Bharath R, et al. A study on rational drug prescribing pattern in geriatric patients in Hyderabad metropolitan. J Drug Deliv Therap. 2012;2(5):109–113. doi: 10.22270/jddt.v2i5.270
  • World Health Organization. Promoting rational use of medicines: core components. 2002. [accessed 2024 May 27]. https://iris.who.int/bitstream/handle/10665/67438/WHO_EDM_2002.3.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.